Europe — EMA
Fenofibrate Accord-Uk Ltd (Fenofibrate Micronised)
Fenofibrate Accord-Uk Ltd is a medication used to manage cholesterol and triglyceride levels. This oral medication helps improve lipid profiles, supporting card
Request sourcing
What is Fenofibrate Micronised?
Fenofibrate Accord-Uk Ltd is a medication used to manage cholesterol and triglyceride levels. This oral medication helps improve lipid profiles, supporting cardiovascular health.
What is Fenofibrate Micronised used for?
Fenofibrate Accord-Uk Ltd is primarily used to lower elevated triglyceride levels and increase HDL (good cholesterol) levels. It is often prescribed for individuals with high cholesterol or mixed dyslipidemia. This medication works by reducing the production of triglycerides in the liver, helping to manage lipid levels in the blood.
What are the side effects of Fenofibrate Micronised?
Common effects of Fenofibrate Accord-Uk Ltd may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience muscle pain or weakness. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.
What precautions apply to Fenofibrate Micronised?
Fenofibrate Accord-Uk Ltd should be used with caution in individuals with liver or kidney disease. Regular monitoring of liver function and lipid levels is recommended. It is important to follow the prescribed dosage and consult a healthcare provider before starting or stopping this medication.
What does Fenofibrate Micronised interact with?
Fenofibrate Accord-Uk Ltd may interact with certain medications, including blood thinners, other cholesterol-lowering drugs, and some antibiotics. Alcohol consumption should be limited, as it can increase the risk of side effects. Always inform your healthcare provider about all medications and supplements you are taking.



